Use of selegiline for the treatment of epileptic disorders

Details Use of selegiline for the treatment of epileptic disorders Use of selegiline for the treatment of epileptic disorders

A - Human Necessities

61

K

A61K 31/137 (2006.01) A61K 31/135 (2006.01) A61P 25/08 (2006.01)

Patent

CA 2197176

The invention concerns the use of selegiline (L-N-(l- phenylisopropyl)-N-methyl-N-propinylamine) or its pharmaceutically usable salts in drugs with an anti-epileptic action.

L'invention concerne l'utilisation de sélégiline (L-N-(1-phényleisopropyle)N-méthyle-N-propinylamine) ou de son sel utilisable sur le plan pharmaceutique dans des médicaments à effet antiépileptique.

Affiliated with

Also associated with

Rating

Use of selegiline for the treatment of epileptic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of selegiline for the treatment of epileptic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selegiline for the treatment of epileptic disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1634891